Surrozen and Consonance-HFW Acquisition Corp. Announce Business Combination, Creating Publicly Listed Leader in Wnt Biology and Tissue Regeneration Portfolio News / By Karina Tin April 15, 2021 Surrozen and Consonance-HFW Acquisition Corp. Announce Business Combination, Creating Publicly Listed Leader in Wnt Biology and Tissue Regeneration Read More »
Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update Portfolio News / By Karina Tin April 13, 2021 Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update Read More »
Synthekine Presents Data at AACR Annual Meeting 2021 Demonstrating Selective IL-2 Partial Agonist, STK-012, Promotes Anti-Tumor Response without Related Toxicities Portfolio News / By Karina Tin April 10, 2021 Synthekine Presents Data at AACR Annual Meeting 2021 Demonstrating Selective IL-2 Partial Agonist, STK-012, Promotes Anti-Tumor Response without Related Toxicities Read More »
Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis Portfolio News / By Karina Tin March 25, 2020 Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis Read More »
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update Portfolio News / By Karina Tin March 23, 2021 ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update Read More »
RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dematitis Portfolio News / By Karina Tin March 22, 2021 RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dematitis Read More »
Carmot Therapeutics expands leadership team with appointment of Manu Chakravarthy, MD, PhD as Chief Medical Officer and Executive Vice President of R&D Portfolio News / By Karina Tin March 16, 2021 Carmot Therapeutics expands leadership team with appointment of Manu Chakravarthy, MD, PhD as Chief Medical Officer and Executive Vice President of R&D Read More »
Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric Cancers Portfolio News / By Karina Tin March 16, 2021 Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric Cancers Read More »
RAPT Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results Portfolio News / By Karina Tin March 11, 2021 RAPT Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results Read More »
Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Portfolio News / By Karina Tin March 9, 2021 Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Read More »
